Showing 241-260 of 498 for: Cochrane Systematic Reviews > Neurologic 
- Intravenous immunoglobulins for epilepsy
Cochrane Systematic Reviews, 2-Dec-2019
Epilepsy is a common neurological condition, with an estimated incidence of 50 per 100,000 persons. People with epilepsy may present with various types of immunological abnormalities, such as low serum immunoglobulin A (IgA) levels, lack of the immunoglob
- Intravenous immunoglobulins for multiple sclerosis
Cochrane Systematic Reviews, 21-Jul-2003
Animal experiments suggest that intravenous immunoglobulins can reverse some of the disease process of central nervous system demyelination. Subsequently, clinical trials of intravenous immunoglobulins have been conducted in people with multiple sclerosis
- Intravenous secretin for autism spectrum disorders (ASD)
Cochrane Systematic Reviews, 18-Apr-2012
In 1998 secretin, a gastrointestinal hormone, was suggested as an effective treatment for autism spectrum disorders (ASD) based on anecdotal evidence.
- Intraventricular antibiotics for bacterial meningitis in neonates
Cochrane Systematic Reviews, 11-Jul-2012
Neonatal meningitis may be caused by bacteria, especially gram-negative bacteria, which are difficult to eradicate from the cerebrospinal fluid (CSF) using safe doses of antibiotics. In theory, intraventricular administration of antibiotics would produce
- Iron for the treatment of restless legs syndrome
Cochrane Systematic Reviews, 4-Jan-2019
Restless legs syndrome (RLS) is a common neurologic disorder that is associated with peripheral iron deficiency in a subgroup of patients. It is unclear whether iron therapy is effective treatment for RLS.
- Ketogenic diets for drug‐resistant epilepsy
Cochrane Systematic Reviews, 24-Jun-2020
Ketogenic diets (KDs) are high in fat and low in carbohydrates and have been suggested to reduce seizure frequency in people with epilepsy. Such diets may be beneficial for children with drug-resistant epilepsy.
- Lamotrigine add‐on therapy for drug‐resistant focal epilepsy
Cochrane Systematic Reviews, 20-Mar-2020
This is an updated version of the Cochrane Review previously published in 2016.
- Lamotrigine add‐on therapy for drug‐resistant generalised tonic‐clonic seizures
Cochrane Systematic Reviews, 1-Jul-2020
This is an update of the Cochrane Review first published in 2010; it includes one additional study.
- Lamotrigine for chronic neuropathic pain and fibromyalgia in adults
Cochrane Systematic Reviews, 28-May-2019
This is an update of the original Cochrane review entitled Lamotrigine for acute and chronic pain published in Issue 2, 2007, and updated in Issue 2, 2011. Some antiepileptic medicines have a place in the treatment of neuropathic pain (pain due to nerve d
- Lamotrigine versus carbamazepine monotherapy for epilepsy: an individual participant data review
Cochrane Systematic Reviews, 28-Jun-2018
This is an updated version of the original Cochrane Review published in Issue 11, 2006 of the Cochrane Database of Systematic Reviews.
- Late (≥ 7 days) systemic postnatal corticosteroids for prevention of bronchopulmonary dysplasia in preterm infants
Cochrane Systematic Reviews, 11-Nov-2021
Many infants born preterm develop bronchopulmonary dysplasia (BPD), with lung inflammation playing a role. Corticosteroids have powerful anti-inflammatory effects and have been used to treat individuals with established BPD. However, it is unclear whether
- Lecithin for dementia and cognitive impairment
Cochrane Systematic Reviews, 23-Oct-2000
Alzheimer's disease sufferers have been found to lack the enzyme responsible for converting choline into acetylcholine within the brain. Lecithin is a major dietary source of choline, so extra consumption may reduce the progression of dementia.
- Levetiracetam add‐on for drug‐resistant focal epilepsy
Cochrane Systematic Reviews, 30-Jun-2020
Drug resistance is common in focal epilepsy. In this update, we summarised the current evidence regarding add-on levetiracetam in treating drug-resistant focal epilepsy. The original review was published in 2001 and last updated in 2012.
- Levodopa for the treatment of restless legs syndrome
Cochrane Systematic Reviews, 24-Mar-2011
Levodopa plus dopamine decarboxylase inhibitor is a common treatment for restless legs syndrome (RLS).
- Lifestyle modification for obstructive sleep apnoea
Cochrane Systematic Reviews, 22-Jan-2001
Obstructive sleep apnoeas are due to transient closure of the upper airway during sleep and merge into hypopnoeas in which the airway narrows, but some airflow continues. They are due to the forces compressing the airway overcoming those which stabilise i
- Light therapy for improving cognition, activities of daily living, sleep, challenging behaviour, and psychiatric disturbances in dementia
Cochrane Systematic Reviews, 25-Feb-2014
Rest-activity and sleep-wake cycles are controlled by the endogenous circadian rhythm generated by the suprachiasmatic nuclei (SCN) of the hypothalamus. Degenerative changes in the SCN appear to be a biological basis for circadian disturbances in people w
- Light therapy for non‐seasonal depression
Cochrane Systematic Reviews, 19-Apr-2004
Efficacy of light therapy for non-seasonal depression has been studied without any consensus on its efficacy.
- Lisuride for levodopa‐induced complications in Parkinson's disease
Cochrane Systematic Reviews, 25-Jan-1999
Long-term levodopa therapy in Parkinson's disease is associated with the development of motor complications including abnormal involuntary movements and a shortening response to each dose (wearing off phenomenon). It is thought that dopamine agonists can
- Lisuride versus bromocriptine for levodopa‐induced complications in Parkinson's disease
Cochrane Systematic Reviews, 25-Jan-1999
Long-term levodopa therapy in Parkinson's disease is associated with the development of motor complications including abnormal involuntary movements and a shortening response to each dose (wearing off phenomenon). It is thought that dopamine agonists can
- Local anaesthetic sympathetic blockade for complex regional pain syndrome
Cochrane Systematic Reviews, 28-Jul-2016
This review is an update of a previously published review in the Cochrane Database of Systematic Reviews, 2005, Issue 4 (and last updated in the Cochrane Database of Systematic Reviews, 2013 issue 8), on local anaesthetic blockade (LASB) of the sympatheti
